Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
about
Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomasDiagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese populationRenal cell carcinoma in tuberous sclerosis complex.Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysisDiagnostic approach to eosinophilic renal neoplasmsClinicopathological features of Xp11.2 translocation renal cell carcinoma.Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrumXp11.2 translocation renal cell carcinomas in young adultsClear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studiesValidation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant articleRenal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.Partial nephrectomy for the treatment of translocation renal cell carcinoma.Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing.Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.The utility of immunohistochemistry for providing genetic information on tumors.Biomarkers in renal cancer.RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas.Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement.Fine-needle aspiration findings of Xp11 translocation renal cell carcinoma metastatic to a hilar lymph node.TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma.Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma.Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press.Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis.Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO-TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum.Do significant TFE3 gene rearrangements occur in succinate dehydrogenase-deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution.Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH.Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report.MicroRNA expression profiling of Xp11 renal cell carcinoma.[The translocation carcinoma: A pediatric renal tumor also in adults].
P2860
Q26752945-0E872ECE-38B6-469C-BF33-502FB8CC1506Q31046172-B51B9A2A-A35B-4A37-B755-80B35F9D8120Q34070195-384A0DAE-BD19-486D-88C9-E53381427D3AQ35005701-13A69EC1-2F9D-41DF-985D-58FBD23F2A6AQ35155653-0B2EE98A-E05E-4368-AC9E-8FF1010F669AQ35164815-BED9DD22-11DD-46B4-A4D7-DDA6790A786EQ35636323-EA92A3F5-46C9-44CA-8DDC-0C4FA04B48F3Q35678902-3E4C0CC6-A7BB-4238-8760-879BCEF632C4Q35738410-2DF7562C-50CA-43F3-ABA9-A9C8B4792B25Q36073126-5465F817-278E-4D1E-8C56-12A409350C82Q36104776-A7457163-8A90-46BC-9AA0-BDE7A321E62DQ36151526-EAFA9935-E507-441B-A13D-E469EFEB7D4BQ36205571-C19599F0-06DE-47AE-AC77-8DF6C887788AQ36288139-9C7A456F-8B91-4CB3-A256-AC603CFF1EB0Q37384169-BC2F4750-E18B-4E3F-A041-A149BDCB4A66Q37623118-B690D62A-3CC0-418E-AAB2-67C5F4DE005BQ38142818-9EA01868-18B4-4EBE-8B1B-C1A111EAF04AQ38184386-58F4A53A-D7FD-4A8A-8D0F-28DED285DEB3Q38375566-45001AB8-8E4B-4DF1-BA26-5B02BE41516AQ39010157-A7054AAB-8B9D-40FB-BD04-85F388EF9A1DQ39116265-0B487764-469A-4BB9-AA67-93F05784B543Q39129490-A5517D83-6285-4CEA-B0A9-833F40E0EE77Q39922019-2A0E57EE-6D7F-484A-B5FC-2B3D4D220745Q40604025-6B02A72C-059B-4E78-A986-D9D536253735Q41670942-BB219EDB-B8E3-4A91-8577-CA4A8E8B47ABQ42364326-F64BFDDB-8BE6-45FF-847A-F70FEA447340Q42773286-D8BCE8C7-6F97-4BAE-81B2-81D99DF13130Q42922556-2CC2E59C-27AC-45F1-8578-DD39932F42EBQ44136116-BE28C239-82FB-49F9-826C-33D352DB47D4Q45066002-8191335A-2205-4CB2-802B-DF53AE444BDFQ46077309-4A23A74E-2117-44C7-B73D-E6ED4E741D8DQ46611738-A7CEE24A-0C3E-48DA-9612-6243BC794B1DQ47965589-002F25E7-4465-41FA-88C6-B9EABA8EF9CBQ48246775-55596944-0A9B-4646-92A7-5D94A8925B22Q48252850-D5DC491C-89D4-4748-867F-566AD6FA98BBQ48284618-CEB4A98C-2524-4FDB-A999-30DD6A4C257EQ48289707-EE44256D-9537-4C9E-BAF4-1E7CEF1ACC33Q49333917-42D34A48-04A7-4A49-8AE5-47A7A2745DDAQ50726690-78D00F06-00D8-4450-B811-BDA7AE3B1B0DQ53149212-E8219859-975B-4FA8-9B13-588A2D0F3F0E
P2860
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
@en
type
label
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
@en
prefLabel
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
@en
P2093
P1476
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
@en
P2093
Constance A Griffin
George J Netto
Jonathan I Epstein
Kerry Morris
Laura Morsberger
Mohamad Allaf
Pedram Argani
Peter B Illei
Raluca Yonescu
Whitney M Green
P304
P356
10.1097/PAS.0B013E31828A69AE
P407
P50
P577
2013-08-01T00:00:00Z